Naoki Morimoto Selected Research

Pigmented Nevus (Melanocytic Nevus)

7/2021	A Novel Treatment for Giant Congenital Melanocytic Nevi Combining Inactivated Autologous Nevus Tissue by High Hydrostatic Pressure and a Cultured Epidermal Autograft: First-in-Human, Open, Prospective Clinical Trial.
6/2021	A Case of Giant Congenital Melanocytic Nevus Treated with Combination Therapy of Autologous Mesh-skin Grafts and Cultured Epithelial Autografts.
5/2021	A Case of a Giant Congenital Melanocytic Nevus Treated by Curettage with the Application of Cultured Epidermal Autografts before 6 Months of Age.
6/2018	Efficacy of Cultured Epithelial Autograft after Curettage for Giant Melanocytic Nevus of the Head.
1/2017	Melanin pigments in the melanocytic nevus regress spontaneously after inactivation by high hydrostatic pressure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoki Morimoto Research Topics

Disease

25	Wounds and Injuries (Trauma) 02/2022 - 05/2005
15	Neoplasms (Cancer) 02/2022 - 01/2002
12	Nevus (Nevi) 12/2021 - 09/2013
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2004
7	Ulcer 02/2022 - 01/2012
7	Skin Ulcer 01/2022 - 05/2005
6	Infections 01/2022 - 01/2013
6	Liver Cirrhosis (Hepatic Cirrhosis) 08/2021 - 08/2004
5	Pigmented Nevus (Melanocytic Nevus) 07/2021 - 01/2017
3	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2013
3	Chronic Hepatitis C 10/2020 - 04/2013
3	Virus Diseases (Viral Diseases) 10/2020 - 04/2013
3	Congenital Abnormalities (Deformity) 08/2019 - 07/2012
2	Inflammation (Inflammations) 02/2022 - 02/2019
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
2	Soft Tissue Infections 01/2022 - 09/2020
2	Hepatitis B 01/2022 - 11/2018
2	Rupture 06/2020 - 07/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 10/2018
2	Melanoma (Melanoma, Malignant) 01/2020 - 06/2018
2	Fatty Liver 02/2019 - 02/2019
2	Carcinoma (Carcinomatosis) 10/2018 - 03/2015
2	Heart Arrest (Cardiac Arrest) 12/2016 - 08/2013
2	Hypoxia (Hypoxemia) 01/2015 - 03/2011
2	Diabetic Foot 12/2014 - 04/2014
2	Cleft Lip (Harelip) 02/2014 - 07/2012
2	Necrosis 01/2014 - 07/2004
1	Surgical Wound Infection 02/2022
1	Fever (Fevers) 02/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Disease Progression 01/2022
1	Hypertrophic Cicatrix (Hypertrophic Scar) 12/2021
1	Fasciitis (Fascitis) 09/2021
1	Hepatic Encephalopathy 08/2021
1	Portal Hypertension 08/2021
1	Contracture 07/2021
1	Fibrosis (Cirrhosis) 02/2021
1	Non-alcoholic Fatty Liver Disease 02/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Malocclusion (Crossbite) 01/2021
1	Ascites 01/2021
1	Hyperbilirubinemia 01/2021

Drug/Important Bio-Agent (IBA)

9	CollagenIBA 09/2021 - 05/2005
6	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2021 - 03/2013
6	GelatinIBA 09/2021 - 09/2013
4	AntigensIBA 01/2022 - 03/2015
4	PlasticsIBA 11/2018 - 01/2016
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2014 - 01/2013
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 06/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2019 - 01/2015
2	Silk FDA Link 01/2022 - 04/2021
2	ElastinIBA 01/2022 - 04/2021
2	Sorafenib (BAY 43-9006)FDA Link 06/2021 - 09/2011
2	SolutionsIBA 04/2021 - 01/2014
2	CholesterolIBA 02/2021 - 02/2019
2	LipidsIBA 02/2021 - 02/2019
2	SofosbuvirIBA 01/2021 - 02/2019
2	Immunoglobulin A (IgA)IBA 07/2020 - 01/2016
2	HCEIBA 06/2017 - 01/2016
2	Hematoxylin (Haematoxylon)IBA 06/2016 - 11/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 06/2016 - 11/2015
2	Polyurethanes (Polyurethane)IBA 04/2016 - 01/2016
2	Saline SolutionIBA 01/2014 - 12/2011
2	N-methyl-nicotineIBA 06/2013 - 04/2008
2	Nicotine FDA Link 06/2013 - 04/2008
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Tumor Necrosis Factor InhibitorsIBA 01/2022
1	tenofovir alafenamideIBA 01/2022
1	FumaratesIBA 01/2022
1	ixekizumabIBA 01/2022
1	pembrolizumabIBA 06/2021
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 04/2021
1	Biocompatible Materials (Biomaterials)IBA 04/2021
1	HydrogelsIBA 04/2021
1	LDL CholesterolIBA 02/2021
1	HDL LipoproteinsIBA 02/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 02/2021
1	BilirubinIBA 01/2021
1	Serum AlbuminIBA 01/2021

Therapy/Procedure

21	Therapeutics 02/2022 - 07/2004
6	Debridement 02/2022 - 01/2012
5	Radiofrequency Ablation 10/2020 - 12/2014
4	Curettage 12/2021 - 06/2018
3	Negative-Pressure Wound Therapy 01/2022 - 02/2015
3	Skin Transplantation (Skin Grafting) 07/2021 - 05/2015
3	Lasers (Laser) 06/2016 - 01/2014
3	Artificial Skin 05/2015 - 01/2012
2	Mammaplasty (Breast Reconstruction) 02/2022 - 01/2022
2	Radiotherapy 01/2022 - 08/2004
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 08/2021 - 01/2021
2	General Anesthesia 06/2019 - 11/2018
2	Rhinoplasty 02/2014 - 07/2012
2	Artificial Respiration (Mechanical Ventilation) 03/2011 - 03/2011
1	Surgical Amputation (Amputations) 01/2022
1	Laser Therapy (Surgery, Laser) 12/2021
1	Surgical Splenorenal Shunt (Splenorenal Shunt) 08/2021
1	Replantation 07/2021
1	Tissue Expansion 06/2021
1	Sutures (Suture) 01/2021